Article info
PDFClinical ethics
Paper
Deception as treatment: the case of depression
- Correspondence to Dr Charlotte Blease, School of Politics, International Studies and Philosophy, Queen's University, 21 University Square, Belfast BT7 1PA, UK; c.blease{at}qub.ac.uk
Citation
Deception as treatment: the case of depression
Publication history
- Received July 27, 2010
- Revised September 7, 2010
- Accepted September 17, 2010
- First published October 20, 2010.
Online issue publication
April 27, 2016
Article Versions
- Previous version (27 April 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2011, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.
Other content recommended for you
- The duty to be Well-informed: The case of depression
- Talking more about talking cures: cognitive behavioural therapy and informed consent
- The moral case for the clinical placebo
- Neurofeedback as placebo: a case of unintentional deception?
- Considering the methodological limitations in the evidence base of antidepressants for depression: a reanalysis of a network meta-analysis
- Antidepressants for the treatment of depression in neurological disorders: a systematic review and meta-analysis of randomised controlled trials
- Electroconvulsive therapy, the placebo effect and informed consent
- Comparative efficacy and acceptability of antidepressants in the long-term treatment of major depression: protocol for a systematic review and networkmeta-analysis
- Efficacy of repetitive transcranial magnetic stimulation in treatment-resistant depression: the evidence thus far
- The concise argument